These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
658 related articles for article (PubMed ID: 26520663)
1. New INH-pyrazole analogs: Design, synthesis and evaluation of antitubercular and antibacterial activity. Nayak N; Ramprasad J; Dalimba U Bioorg Med Chem Lett; 2015 Dec; 25(23):5540-5. PubMed ID: 26520663 [TBL] [Abstract][Full Text] [Related]
2. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents. Lokesh BVS; Prasad YR; Shaik AB Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and antimycobacterial activity of 5-aryl-1-isonicotinoyl-3-(pyridin-2-yl)-4, 5-dihydro-1H-pyrazole derivatives. Mamolo MG; Zampieri D; Falagiani V; Vio L; Banfi E Farmaco; 2001 Aug; 56(8):593-9. PubMed ID: 11601645 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and antitubercular activity of substituted novel pyrazoline derivatives. Ali MA; Yar MS; Kumar M; Pandian GS Nat Prod Res; 2007 Jun; 21(7):575-9. PubMed ID: 17613813 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and antitubercular activity of novel 3,5-diaryl-4,5-dihydro-1H-pyrazole derivatives. Alegaon SG; Alagawadi KR; Dadwe DH Drug Res (Stuttg); 2014 Oct; 64(10):553-8. PubMed ID: 24446205 [TBL] [Abstract][Full Text] [Related]
6. Structure-based design of some isonicotinic acid hydrazide analogues as potential antitubercular agents. Atta A; Fahmy S; Rizk O; Sriram D; Mahran MA; Labouta IM Bioorg Chem; 2018 Oct; 80():721-732. PubMed ID: 30077175 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and antimycobacterial evaluation of novel 3-substituted-N-aryl-6,7-dimethoxy-3a,4-dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide analogues. Ahsan MJ; Samy JG; Dutt KR; Agrawal UK; Yadav BS; Vyas S; Kaur R; Yadav G Bioorg Med Chem Lett; 2011 Aug; 21(15):4451-3. PubMed ID: 21733688 [TBL] [Abstract][Full Text] [Related]
8. Design of new phenothiazine-thiadiazole hybrids via molecular hybridization approach for the development of potent antitubercular agents. Ramprasad J; Nayak N; Dalimba U Eur J Med Chem; 2015 Dec; 106():75-84. PubMed ID: 26520841 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of novel substituted pyrazolyl-2-toluidinomethanethione and pyrazolyl-2-methoxyanilinomethanethione as potential antitubercular agents. Ali MA; Yar MS Acta Pol Pharm; 2007; 64(2):139-46. PubMed ID: 17665863 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of novel isoniazid derivatives with potent antitubercular activity. Martins F; Santos S; Ventura C; Elvas-Leitão R; Santos L; Vitorino S; Reis M; Miranda V; Correia HF; Aires-de-Sousa J; Kovalishyn V; Latino DA; Ramos J; Viveiros M Eur J Med Chem; 2014 Jun; 81():119-38. PubMed ID: 24836065 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and in vitro antimycobacterial activity of 3-substituted 5-hydroxy-5-trifluoro[chloro]methyl-4,5-dihydro-1H-1-(isonicotinoyl) pyrazoles. Almeida da Silva PE; Ramos DF; Bonacorso HG; de la Iglesia AI; Oliveira MR; Coelho T; Navarini J; Morbidoni HR; Zanatta N; Martins MA Int J Antimicrob Agents; 2008 Aug; 32(2):139-44. PubMed ID: 18571384 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, antitubercular and antimicrobial evaluation of 3-(4-chlorophenyl)-4-substituted pyrazole derivatives. Pathak RB; Chovatia PT; Parekh HH Bioorg Med Chem Lett; 2012 Aug; 22(15):5129-33. PubMed ID: 22695129 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1,3,4-oxadiazole derivatives as potential antitubercular agents. Desai NC; Somani H; Trivedi A; Bhatt K; Nawale L; Khedkar VM; Jha PC; Sarkar D Bioorg Med Chem Lett; 2016 Apr; 26(7):1776-83. PubMed ID: 26920799 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of novel 1,2,3-triazole derivatives of isoniazid and their in vitro and in vivo antimycobacterial activity evaluation. Kumar D; Beena ; Khare G; Kidwai S; Tyagi AK; Singh R; Rawat DS Eur J Med Chem; 2014 Jun; 81():301-13. PubMed ID: 24852277 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, in silico, and in vitro evaluation of 3-phenylpyrazole acetamide derivatives as antimycobacterial agents. Gaikwad NB; Nirmale K; Sahoo SK; Ahmad MN; Kaul G; Shukla M; Nanduri S; Das Gupta A; Chopra S; Yaddanapudi MV Arch Pharm (Weinheim); 2021 May; 354(5):e2000349. PubMed ID: 33351199 [TBL] [Abstract][Full Text] [Related]
16. Development of gallic acid formazans as novel enoyl acyl carrier protein reductase inhibitors for the treatment of tuberculosis. Saharan VD; Mahajan SS Bioorg Med Chem Lett; 2017 Feb; 27(4):808-815. PubMed ID: 28117201 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and in-vitro antimycobacterial activity of amino-5-[(substituted) phenyl]-3-(4-hydroxy-3-methylphenyl)-4,5-dihydro-1H-1-pyrazolylmethanethione. Ali MA; Yar MS; Siddiqui AA; Husain A; Abdullah M Acta Pol Pharm; 2007; 64(5):435-9. PubMed ID: 18540164 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of substituted 4,6-diarylpyrimidines and 3,5-diphenyl-4,5-dihydro-1H-pyrazoles as anti-tubercular agents. Pathak V; Maurya HK; Sharma S; Srivastava KK; Gupta A Bioorg Med Chem Lett; 2014 Jul; 24(13):2892-6. PubMed ID: 24835631 [TBL] [Abstract][Full Text] [Related]